John Ransom
Stock Analyst at Raymond James
(4.62)
# 211
Out of 4,981 analysts
211
Total ratings
66.32%
Success rate
16.03%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Downgrades: Outperform | $40 → $26 | $21.73 | +19.65% | 9 | Aug 14, 2025 | |
| RDNT RadNet | Reiterates: Strong Buy | $66 → $75 | $74.07 | +1.26% | 12 | Aug 13, 2025 | |
| AVAH Aveanna Healthcare Holdings | Upgrades: Outperform | $9 | $8.44 | +6.64% | 8 | Aug 11, 2025 | |
| SCI Service Corporation International | Reiterates: Outperform | $85 → $90 | $80.09 | +12.37% | 13 | Aug 4, 2025 | |
| THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $192.82 | +3.72% | 18 | Jul 23, 2025 | |
| CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $302.76 | +27.16% | 18 | May 5, 2025 | |
| UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $352.51 | +53.19% | 13 | Apr 21, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $405.13 | - | 21 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $2.94 | - | 8 | Nov 22, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.19 | +138.66% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $85 → $95 | $126.05 | -24.63% | 15 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $276.44 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $19.33 | +3.47% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $24.19 | +24.02% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $16.04 | -25.19% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $74.98 | +13.36% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $110.37 | -4.86% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $6.20 | +61.29% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $3.13 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $26.60 | - | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $43.50 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $28.88 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $133.17 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $21.87 | - | 2 | Aug 9, 2017 |
Acadia Healthcare Company
Aug 14, 2025
Downgrades: Outperform
Price Target: $40 → $26
Current: $21.73
Upside: +19.65%
RadNet
Aug 13, 2025
Reiterates: Strong Buy
Price Target: $66 → $75
Current: $74.07
Upside: +1.26%
Aveanna Healthcare Holdings
Aug 11, 2025
Upgrades: Outperform
Price Target: $9
Current: $8.44
Upside: +6.64%
Service Corporation International
Aug 4, 2025
Reiterates: Outperform
Price Target: $85 → $90
Current: $80.09
Upside: +12.37%
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $192.82
Upside: +3.72%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $302.76
Upside: +27.16%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $352.51
Upside: +53.19%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $405.13
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $2.94
Upside: -
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.19
Upside: +138.66%
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $126.05
Upside: -24.63%
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $276.44
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $19.33
Upside: +3.47%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $24.19
Upside: +24.02%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $16.04
Upside: -25.19%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $74.98
Upside: +13.36%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $110.37
Upside: -4.86%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $6.20
Upside: +61.29%
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $3.13
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $26.60
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $43.50
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $28.88
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $133.17
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $21.87
Upside: -